KRAS and colorectal carcinoma: Other mutations in PIK3CA, SMAD4, and TP53 facilitate malignant growth with the potential for invasion.131KRAS mutations occur in ~40% of cases, and the most common KRAS mutation subtypes in CRC are KRASG12D and KRASG12V.